Details of Disease

General Information of Disease (ID: DISBP0IU)

Disease Name Cancer related pain
Disease Class MG30: Chronic pain
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISBP0IU: Cancer related pain
ICD Code
ICD-11
ICD-11: MG30
ICD-10
ICD-10: R52.1, R52.2
Expand ICD-9
140,141,142,143,144,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 6 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Alpha 1-PI DMXC1K9 Approved Small molecular drug [1]
Fentanyl DM8WAHT Approved Small molecular drug [2]
Samarium Sm-153 Lexidronam Pentasodium DM62MUZ Approved Small molecular drug [3]
Strontium Chloride Sr-89 DMCRD0D Approved Small molecular drug [3]
Mirogabalin DM5GIWZ Registered Small molecular drug [4]
Dihydrocodeine DMB0FWL Phase 4 Small molecular drug [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
This Disease is Treated as An Indication in 10 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Fulranumab DMK38MV Phase 3 Monoclonal antibody [6]
Nabiximols DMHKJ5I Phase 3 Small molecular drug [7]
Tanezumab DMJKWMA Phase 3 Monoclonal antibody [8]
Flupirtine DMPBV9D Phase 2 Small molecular drug [9]
Neramexane DM3ORVD Phase 2 Small molecular drug [10]
NP-2 gene therapy DMZ6JTK Phase 2 NA [11]
Resiniferatoxin DMP62L5 Phase 2 Small molecular drug [4]
XEN-2174 DM0NFMS Phase 2 NA [12]
DWJ-208 DMQKDJZ Phase 1 NA [13]
OX-27 DMDY2RV Phase 1 NA [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
This Disease is Treated as An Indication in 163 Patented Agent(s)
Drug Name Drug ID Highest Status Drug Type REF
PMID25666693-Compound-1 DMEL1WX Patented Small molecular drug [15]
PMID25666693-Compound-10 DMQP3TD Patented Small molecular drug [15]
PMID25666693-Compound-100 DMYTZFP Patented Small molecular drug [15]
PMID25666693-Compound-101 DMNOD4A Patented Small molecular drug [15]
PMID25666693-Compound-102 DM0OY5D Patented Small molecular drug [15]
PMID25666693-Compound-103 DM8DZA6 Patented Small molecular drug [15]
PMID25666693-Compound-104 DMYCT5B Patented Small molecular drug [15]
PMID25666693-Compound-105 DMV509A Patented Small molecular drug [15]
PMID25666693-Compound-106 DMEG8CB Patented Small molecular drug [15]
PMID25666693-Compound-107 DMB2RML Patented Small molecular drug [15]
PMID25666693-Compound-108 DMN0FCA Patented Small molecular drug [15]
PMID25666693-Compound-109 DMWGIS7 Patented Small molecular drug [15]
PMID25666693-Compound-11 DM9HOM6 Patented Small molecular drug [15]
PMID25666693-Compound-110 DMNGD2S Patented Small molecular drug [15]
PMID25666693-Compound-111 DMNKW1E Patented Small molecular drug [15]
PMID25666693-Compound-112 DMQOSH5 Patented Small molecular drug [15]
PMID25666693-Compound-113 DM02O5V Patented Small molecular drug [15]
PMID25666693-Compound-114 DMA9YDK Patented Small molecular drug [15]
PMID25666693-Compound-115 DMF5ODZ Patented Small molecular drug [15]
PMID25666693-Compound-116 DMNEBXL Patented Small molecular drug [15]
PMID25666693-Compound-117 DMN9LDH Patented Small molecular drug [15]
PMID25666693-Compound-118 DMBIQMS Patented Small molecular drug [15]
PMID25666693-Compound-119 DMD0WIA Patented Small molecular drug [15]
PMID25666693-Compound-12 DMVSFNE Patented Small molecular drug [15]
PMID25666693-Compound-120 DMVREIM Patented Small molecular drug [15]
PMID25666693-Compound-121 DMC1QDB Patented Small molecular drug [15]
PMID25666693-Compound-122 DMR63O2 Patented Small molecular drug [15]
PMID25666693-Compound-123 DM9358G Patented Small molecular drug [15]
PMID25666693-Compound-124 DM6ODU7 Patented Small molecular drug [15]
PMID25666693-Compound-125 DMR0WM1 Patented Small molecular drug [15]
PMID25666693-Compound-126 DMKN72Y Patented Small molecular drug [15]
PMID25666693-Compound-127 DMCE6MB Patented Small molecular drug [15]
PMID25666693-Compound-128 DM6QHGV Patented Small molecular drug [15]
PMID25666693-Compound-129 DM74NBY Patented Small molecular drug [15]
PMID25666693-Compound-13 DMI0YWU Patented Small molecular drug [15]
PMID25666693-Compound-130 DMIX1K0 Patented Small molecular drug [15]
PMID25666693-Compound-131 DML7SYH Patented Small molecular drug [15]
PMID25666693-Compound-132 DMHQM8W Patented Small molecular drug [15]
PMID25666693-Compound-133 DMHEPR3 Patented Small molecular drug [15]
PMID25666693-Compound-134 DM2WJKR Patented Small molecular drug [15]
PMID25666693-Compound-135 DMYZVPD Patented Small molecular drug [15]
PMID25666693-Compound-136 DMPY1QC Patented Small molecular drug [15]
PMID25666693-Compound-137 DMZ7LAO Patented Small molecular drug [15]
PMID25666693-Compound-138 DMJLFEN Patented Small molecular drug [15]
PMID25666693-Compound-139 DMLMEPI Patented Small molecular drug [15]
PMID25666693-Compound-14 DM3D4RI Patented Small molecular drug [15]
PMID25666693-Compound-140 DMVQU9T Patented Small molecular drug [15]
PMID25666693-Compound-141 DMQGTYE Patented Small molecular drug [15]
PMID25666693-Compound-142 DMFKN1O Patented Small molecular drug [15]
PMID25666693-Compound-143 DMJP0NB Patented Small molecular drug [15]
PMID25666693-Compound-144 DMCXELD Patented Small molecular drug [15]
PMID25666693-Compound-145 DMP89E4 Patented Small molecular drug [15]
PMID25666693-Compound-146 DMLE5BK Patented Small molecular drug [15]
PMID25666693-Compound-147 DMG1SYN Patented Small molecular drug [15]
PMID25666693-Compound-148 DM0EYON Patented Small molecular drug [15]
PMID25666693-Compound-149 DMPU19H Patented Small molecular drug [15]
PMID25666693-Compound-15 DM1G6AE Patented Small molecular drug [15]
PMID25666693-Compound-150 DMHMEFY Patented Small molecular drug [15]
PMID25666693-Compound-151 DM5CY86 Patented Small molecular drug [15]
PMID25666693-Compound-152 DM27154 Patented Small molecular drug [15]
PMID25666693-Compound-153 DM1FTV6 Patented Small molecular drug [15]
PMID25666693-Compound-154 DMKNU0Z Patented Small molecular drug [15]
PMID25666693-Compound-155 DMZLB07 Patented Small molecular drug [15]
PMID25666693-Compound-156 DMTVAUP Patented Small molecular drug [15]
PMID25666693-Compound-157 DME8LUY Patented Small molecular drug [15]
PMID25666693-Compound-158 DM2BTCU Patented Small molecular drug [15]
PMID25666693-Compound-159 DM74OGS Patented Small molecular drug [15]
PMID25666693-Compound-16 DM6SL9D Patented Small molecular drug [15]
PMID25666693-Compound-160 DM2KTAB Patented Small molecular drug [15]
PMID25666693-Compound-161 DM06IWA Patented Small molecular drug [15]
PMID25666693-Compound-162 DMXS5WY Patented Small molecular drug [15]
PMID25666693-Compound-17 DMRK1W7 Patented Small molecular drug [15]
PMID25666693-Compound-18 DMKU6C3 Patented Small molecular drug [15]
PMID25666693-Compound-19 DM63UM8 Patented Small molecular drug [15]
PMID25666693-Compound-2 DMERD39 Patented Small molecular drug [15]
PMID25666693-Compound-20 DM3I90D Patented Small molecular drug [15]
PMID25666693-Compound-21 DMUXO47 Patented Small molecular drug [15]
PMID25666693-Compound-22 DMHPW3X Patented Small molecular drug [15]
PMID25666693-Compound-23 DMJ3YDT Patented Small molecular drug [15]
PMID25666693-Compound-24 DMUMYKX Patented Small molecular drug [15]
PMID25666693-Compound-25 DMI8CB3 Patented Small molecular drug [15]
PMID25666693-Compound-26 DMQBFI2 Patented Small molecular drug [15]
PMID25666693-Compound-27 DMKHO8T Patented Small molecular drug [15]
PMID25666693-Compound-28 DM7T962 Patented Small molecular drug [15]
PMID25666693-Compound-29 DM02D1B Patented Small molecular drug [15]
PMID25666693-Compound-3 DMN692C Patented Small molecular drug [15]
PMID25666693-Compound-30 DMC3DT7 Patented Small molecular drug [15]
PMID25666693-Compound-31 DM853Y7 Patented Small molecular drug [15]
PMID25666693-Compound-32 DM58Z4M Patented Small molecular drug [15]
PMID25666693-Compound-33 DMW7981 Patented Small molecular drug [15]
PMID25666693-Compound-34 DMWGAQU Patented Small molecular drug [15]
PMID25666693-Compound-35 DMG9CPH Patented Small molecular drug [15]
PMID25666693-Compound-36 DMWVR81 Patented Small molecular drug [15]
PMID25666693-Compound-37 DMSR218 Patented Small molecular drug [15]
PMID25666693-Compound-38 DMBW36Y Patented Small molecular drug [15]
PMID25666693-Compound-39 DML3KHF Patented Small molecular drug [15]
PMID25666693-Compound-4 DMBD9S5 Patented Small molecular drug [15]
PMID25666693-Compound-40 DM58QW1 Patented Small molecular drug [15]
PMID25666693-Compound-41 DML76MF Patented Small molecular drug [15]
PMID25666693-Compound-42 DM6I49E Patented Small molecular drug [15]
PMID25666693-Compound-43 DMTN25V Patented Small molecular drug [15]
PMID25666693-Compound-44 DM0I72B Patented Small molecular drug [15]
PMID25666693-Compound-45 DMVDKXY Patented Small molecular drug [15]
PMID25666693-Compound-46 DM0MEXT Patented Small molecular drug [15]
PMID25666693-Compound-47 DMHBN5M Patented Small molecular drug [15]
PMID25666693-Compound-48 DMEVL0S Patented Small molecular drug [15]
PMID25666693-Compound-49 DM67DEG Patented Small molecular drug [15]
PMID25666693-Compound-5 DM53PBG Patented Small molecular drug [15]
PMID25666693-Compound-50 DM4GUZO Patented Small molecular drug [15]
PMID25666693-Compound-51 DM3KSV9 Patented Small molecular drug [15]
PMID25666693-Compound-52 DMQPOGC Patented Small molecular drug [15]
PMID25666693-Compound-53 DMKCARH Patented Small molecular drug [15]
PMID25666693-Compound-54 DMLW95Y Patented Small molecular drug [15]
PMID25666693-Compound-55 DMPE7M8 Patented Small molecular drug [15]
PMID25666693-Compound-56 DM82BAM Patented Small molecular drug [15]
PMID25666693-Compound-57 DMQRFXT Patented Small molecular drug [15]
PMID25666693-Compound-58 DMJEH0F Patented Small molecular drug [15]
PMID25666693-Compound-59 DMLI1YR Patented Small molecular drug [15]
PMID25666693-Compound-6 DMC5W1Y Patented Small molecular drug [15]
PMID25666693-Compound-60 DM2C58A Patented Small molecular drug [15]
PMID25666693-Compound-61 DM0B578 Patented Small molecular drug [15]
PMID25666693-Compound-62 DMDMFJG Patented Small molecular drug [15]
PMID25666693-Compound-63 DM6DFAK Patented Small molecular drug [15]
PMID25666693-Compound-64 DMDWH8T Patented Small molecular drug [15]
PMID25666693-Compound-65 DM1A0GT Patented Small molecular drug [15]
PMID25666693-Compound-66 DMD13OS Patented Small molecular drug [15]
PMID25666693-Compound-67 DMPV9L2 Patented Small molecular drug [15]
PMID25666693-Compound-68 DM87HTO Patented Small molecular drug [15]
PMID25666693-Compound-69 DMIPFO3 Patented Small molecular drug [15]
PMID25666693-Compound-7 DMNTVFH Patented Small molecular drug [15]
PMID25666693-Compound-70 DMEPYGQ Patented Small molecular drug [15]
PMID25666693-Compound-71 DM4VAQ3 Patented Small molecular drug [15]
PMID25666693-Compound-72 DMW8XD2 Patented Small molecular drug [15]
PMID25666693-Compound-73 DM9LZJ5 Patented Small molecular drug [15]
PMID25666693-Compound-74 DM80E3F Patented Small molecular drug [15]
PMID25666693-Compound-75 DMNATSQ Patented Small molecular drug [15]
PMID25666693-Compound-76 DMYH429 Patented Small molecular drug [15]
PMID25666693-Compound-77 DM05D48 Patented Small molecular drug [15]
PMID25666693-Compound-78 DMQI1YN Patented Small molecular drug [15]
PMID25666693-Compound-79 DMTQ26G Patented Small molecular drug [15]
PMID25666693-Compound-8 DMZQ6HC Patented Small molecular drug [15]
PMID25666693-Compound-80 DMB56LS Patented Small molecular drug [15]
PMID25666693-Compound-81 DM5ZELW Patented Small molecular drug [15]
PMID25666693-Compound-82 DM1MZ70 Patented Small molecular drug [15]
PMID25666693-Compound-83 DM2ZVXD Patented Small molecular drug [15]
PMID25666693-Compound-84 DM4QYIJ Patented Small molecular drug [15]
PMID25666693-Compound-85 DMGVU7M Patented Small molecular drug [15]
PMID25666693-Compound-86 DMFZ3S4 Patented Small molecular drug [15]
PMID25666693-Compound-87 DMAV4XY Patented Small molecular drug [15]
PMID25666693-Compound-88 DMT9EJL Patented Small molecular drug [15]
PMID25666693-Compound-89 DM6RQKH Patented Small molecular drug [15]
PMID25666693-Compound-9 DM8A4B5 Patented Small molecular drug [15]
PMID25666693-Compound-90 DM26NQE Patented Small molecular drug [15]
PMID25666693-Compound-91 DMXU3IE Patented Small molecular drug [15]
PMID25666693-Compound-92 DMRGOZ8 Patented Small molecular drug [15]
PMID25666693-Compound-93 DMM5EI4 Patented Small molecular drug [15]
PMID25666693-Compound-94 DMHREX9 Patented Small molecular drug [15]
PMID25666693-Compound-95 DMFNB1T Patented Small molecular drug [15]
PMID25666693-Compound-96 DME3NTB Patented Small molecular drug [15]
PMID25666693-Compound-97 DMHJOP7 Patented Small molecular drug [15]
PMID25666693-Compound-98 DM2ZR8M Patented Small molecular drug [15]
PMID25666693-Compound-99 DMOISDH Patented Small molecular drug [15]
PMID27998201-Compound-12 DM8QZNC Patented Small molecular drug [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 163 Drug(s)
This Disease is Treated as An Indication in 6 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Propiram fumarate DMW9H7M Discontinued in Phase 3 Small molecular drug [17]
BL-1827 DMJWLBU Discontinued in Phase 1 NA [18]
ACEA-1328 DMEH9OY Terminated NA [19]
DBO-11 DM8GHT2 Terminated Small molecular drug [20]
DBO-17 DMFJ3UW Terminated NA [21]
RO-25-6981 DM3H921 Terminated Small molecular drug [22]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
This Disease is Treated as An Indication in 2 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
SP-SAP DMKCJQW Investigative NA [23]
THA-901 DMDBV07 Investigative NA [24]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5472).
2 ClinicalTrials.gov (NCT00822614) Safety of Fentanyl TAIFUN Treatment. U.S. National Institutes of Health.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7594).
6 ClinicalTrials.gov (NCT02336685) Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001. U.S. National Institutes of Health.
7 Clinical pipeline report, company report or official report of GW Pharmaceuticals.
8 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8415).
9 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2598).
10 Emerging analgesics in cancer pain management. Expert Opin Emerg Drugs. 2005 Feb;10(1):151-71.
11 Clinical pipeline report, company report or official report of Diamyd Medical.
12 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021315)
13 Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
14 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033740)
15 Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):291-318.
16 Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
17 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003460)
18 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013581)
19 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007690)
20 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009577)
21 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009580)
22 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009657)
23 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 360).
24 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.